What is the initial insulin therapy regimen for patients with diabetes?

Initial Insulin Therapy Regimen for Patients with Diabetes

Type 1 Diabetes

For patients with type 1 diabetes, initiate insulin at approximately one-third of total daily insulin requirements as basal insulin (typically 0.4-1.0 units/kg/day total, with 0.5 units/kg/day being standard for metabolically stable patients), with the remainder provided as short-acting or rapid-acting insulin before meals. 1, 2, 3

Starting Regimen

• Basal insulin: Approximately 40-50% of total daily dose, administered once daily at the same time each day 2, 3
• Prandial insulin: Remaining 50-60% divided among meals using rapid-acting insulin analogs (lispro, aspart, or glulisine) administered 0-15 minutes before eating 1, 4
• For a metabolically stable patient, start with 0.5 units/kg/day total insulin 2
• Example: A 50kg patient would receive approximately 25 units total daily—about 12-13 units as basal insulin and 12-13 units divided among three meals 2

Special Considerations

• Higher doses required immediately following ketoacidosis presentation 2
• Multiple daily injections are typically initiated at diagnosis 4
• Insulin analogs are preferred over human insulin to reduce hypoglycemia risk 1

---

Type 2 Diabetes

For insulin-naive patients with type 2 diabetes, start with basal insulin at 10 units once daily OR 0.1-0.2 units/kg/day, administered at the same time each day, typically in conjunction with metformin. 1, 2, 3

Clinical Decision Algorithm

Mild to Moderate Hyperglycemia (A1C <9%)

• Start 10 units of basal insulin once daily OR 0.1-0.2 units/kg/day 1, 2, 3
• Continue metformin and possibly one additional non-insulin agent 1
• Titrate by 2-4 units every 3 days until fasting glucose reaches 80-130 mg/dL 2, 5

Moderate Hyperglycemia (A1C ≥9%)

• Consider starting at 0.2 units/kg/day of basal insulin 5
• May initiate dual therapy (basal insulin + oral agents) immediately 1
• More aggressive titration: increase by 4 units every 3 days if fasting glucose ≥180 mg/dL 5

Severe Hyperglycemia (Blood glucose ≥300-350 mg/dL and/or A1C ≥10-12%, especially with symptoms or catabolic features)

• Immediately initiate basal-bolus insulin regimen 1, 5
• Start with 0.2 units/kg/day basal insulin PLUS 4 units rapid-acting insulin before the largest meal 5
• This is the preferred initial regimen for severe presentations 1
• Continue or initiate metformin unless contraindicated 5

Titration Protocol

• If fasting glucose ≥180 mg/dL: Increase basal insulin by 4 units every 3 days 2, 5
• If fasting glucose 140-179 mg/dL: Increase by 2 units every 3 days 2, 5
• If fasting glucose <80 mg/dL (more than 2 values/week): Decrease by 2 units 2
• Target fasting glucose: 80-130 mg/dL 2, 5

When to Add Prandial Insulin

Add prandial insulin when basal insulin has been optimized (fasting glucose at target) but A1C remains above goal after 3-6 months, OR when basal insulin dose approaches 0.5-1.0 units/kg/day without achieving A1C goal. 1, 2, 5

• Start with 4 units of rapid-acting insulin before the largest meal OR 10% of current basal dose 1, 2, 5
• Titrate prandial insulin by 1-2 units or 10-15% every 3 days based on postprandial glucose 5
• Add to additional meals as needed based on glucose patterns 5

---

Critical Pitfalls to Avoid

Overbasalization

Do not continue escalating basal insulin beyond 0.5-1.0 units/kg/day without addressing postprandial hyperglycemia. 2, 5

• Warning signs: Basal dose >0.5 units/kg/day, bedtime-to-morning glucose differential ≥50 mg/dL, hypoglycemia, high glucose variability 2
• When these occur, add prandial insulin rather than further increasing basal insulin 2, 5

Delayed Insulin Initiation

• Do not delay insulin therapy in patients not achieving glycemic goals with oral medications—this can be harmful 2
• For severe hyperglycemia (A1C ≥10-12% with symptoms), immediate basal-bolus insulin is required, not gradual escalation 1, 5

Foundation Therapy

• Continue metformin when initiating or intensifying insulin therapy unless contraindicated 1, 5
• Metformin reduces weight gain, lowers insulin requirements, and decreases hypoglycemia risk when combined with insulin 4
• Do not abruptly discontinue oral medications when starting insulin due to risk of rebound hyperglycemia 4

Injection Technique

• Use shortest needles available (4mm pen, 6mm syringe) to avoid intramuscular injection 4
• Rotate injection sites within the same region (abdomen, thigh, or deltoid) to prevent lipodystrophy 3, 4
• Never inject into areas of lipodystrophy—this causes erratic absorption and hyperglycemia 3

---

Monitoring Requirements

• Daily fasting blood glucose monitoring during titration phase 2, 5
• Reassess every 3 days during active titration 5
• Check A1C every 3-6 months once stable 5
• Equip patients with self-titration algorithms based on self-monitoring of blood glucose 1

---

Special Populations

Pediatric Type 2 Diabetes

• If A1C ≥8.5% without acidosis/ketosis: Start 0.5 units/kg/day basal insulin plus metformin 1
• If ketoacidosis present: Treat with IV insulin until acidosis resolves, then transition to subcutaneous regimen 1

Hospitalized Patients

• Insulin-naive or low-dose insulin: Start 0.3-0.5 units/kg/day total daily dose, with half as basal insulin 2
• High-dose home insulin (≥0.6 units/kg/day): Reduce total daily dose by 20% to prevent hypoglycemia 2
• High-risk patients (elderly >65 years, renal failure, poor oral intake): Use lower doses of 0.1-0.25 units/kg/day 2